Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2011

Open Access 01-12-2011 | Research

Rapid S-nitrosylation of actin by NO-generating donors and in inflammatory pain model mice

Authors: Jingshan Lu, Tayo Katano, Daisuke Uta, Hidemasa Furue, Seiji Ito

Published in: Molecular Pain | Issue 1/2011

Login to get access

Abstract

Background

S-Nitrosylation, the reversible post-translational modification of reactive cysteine residues in proteins, has emerged as an important mechanism by which NO acts as a signaling molecule. We recently demonstrated that actin is a major S-nitrosylated protein in the spinal cord and suggested that NO directly attenuates dopamine release from PC12 cells by causing the breakdown of F-actin. However, the occurrence of S-nitrosylation of actin remained unclarified in animal pain model. Kinetic analysis of S-nitrosylation of actin in the present study was made by using NO-generating donors. The biotin-switch assay and purification on streptavidin-agarose were employed for identification of S-nitrosylated actin.

Results

Dopamine release from PC12 cells was markedly attenuated by NOR1 (t 1/2 = 1.8 min) and much less by NOR3 (t 1/2 = 30 min), but not by S-nitroso-glutathione, an endogenous NO donor. A membrane-permeable cGMP analogue could not substitute for NOR1 as a suppressor nor could inhibitors of soluble guanylate cyclase and cGMP-dependent protein kinase attenuate the suppression. S-Nitrosylated actin was detected by the biotin-switch assay at 5 min after the addition of NOR1. Consistent with the kinetic analysis, actin in the spinal cord was rapidly and maximally S-nitrosylated in an inflammatory pain model at 5 min after the injection of 2% formalin into the hind paws. In vivo patch-clamp recordings of the spinal dorsal horn, NOR3 showed an inhibitory action on inhibitory synaptic transmission in interneurons of the substantia gelatinosa.

Conclusions

The present study demonstrates that rapid S-nitrosylation of actin occurred in vitro in the presence of exogenous NO-generating donors and in vivo in inflammatory pain model mice. Our data suggest that, in addition to the well-known cGMP-dependent protein kinase pathway, S-nitrosylation is involved in pain transmission via disinhibition of inhibitory neurons.
Appendix
Available only for authorised users
Literature
1.
2.
Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG: Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000, 3: 661–669. 10.1038/76615PubMedCrossRef
3.
Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52: 127–136. 10.1016/0304-3959(93)90124-8PubMedCrossRef
4.
Ji RR, Kohno T, Moore KA, Woolf CJ: Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 2003, 26: 696–705. 10.1016/j.tins.2003.09.017PubMedCrossRef
5.
Hofmann H, Feil R, Kleppisch T, Schlossmann J: Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 2006, 86: 1–23. 10.1152/physrev.00015.2005PubMedCrossRef
6.
Schmidtko A, Tegeder I, Geisslinger G: No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci 2009, 32: 339–346. 10.1016/j.tins.2009.01.010PubMedCrossRef
7.
Meller ST, Dykstra C, Gebhart GF: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N -methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol 1992, 214: 93–96. 10.1016/0014-2999(92)90102-APubMedCrossRef
8.
Minami T, Nishihara I, Ito S, Sakamoto K, Hyodo M, Hayaishi O: Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E 2 or prostaglandin F 2α in conscious mice. Pain 1995, 61: 285–290. 10.1016/0304-3959(94)00183-FPubMedCrossRef
9.
Sluka KA, Willis WD: Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor. Brain Res 1998, 798: 281–286. 10.1016/S0006-8993(98)00428-4PubMedCrossRef
10.
Tao YX, Johns RA: Activation of cGMP-dependent protein kinase Iα is required for N -methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur J Pharmacol 2000, 392: 141–145. 10.1016/S0014-2999(00)00129-1PubMedCrossRef
11.
Malmberg AB, Yaksh TL: The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E 2 using microdialysis in conscious rats. Br J Pharmacol 1995, 114: 1069–1075.PubMedCentralPubMedCrossRef
12.
Pehl U, Schmid HA: Electrophysiological responses of neurons in the rat spinal cord to nitric oxide. Neuroscience 1997, 77: 563–573. 10.1016/S0306-4522(96)00495-2PubMedCrossRef
13.
Hoheisel U, Unger T, Mense S: A block of spinal nitric oxide synthesis leads to increased background activity predominantly in nociceptive dorsal horn neurones in the rat. Pain 2000, 88: 249–257. 10.1016/S0304-3959(00)00336-5PubMedCrossRef
14.
Sousa AM, Prado WA: The dual effect of a nitric oxide donor in nociception. Brain Res 2001, 897: 9–19. 10.1016/S0006-8993(01)01995-3PubMedCrossRef
15.
Tegeder I, Schmidtko A, Niederberger E, Ruth P, Geisslinger G: Dual effects of spinally delivered 8-bromo-cyclic guanosine monophosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci Lett 2002, 332: 146–150. 10.1016/S0304-3940(02)00938-2PubMedCrossRef
16.
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6: 150–166. 10.1038/nrm1569PubMedCrossRef
17.
Ahern GP, Klyachko VA, Jackson MB: GMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci 2002, 25: 510–517. 10.1016/S0166-2236(02)02254-3PubMedCrossRef
18.
Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH: Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 2001, 3: 193–197. 10.1038/35055104PubMedCrossRef
19.
Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, Lipton SA: Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 2000, 3: 15–21. 10.1038/71090PubMedCrossRef
20.
Sayed N, Baskaran P, Ma X, Akker F, van den Beuve A: Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 2007, 104: 12312–12317. 10.1073/pnas.0703944104PubMedCentralPubMedCrossRef
21.
Lu J, Katano T, Okuda-Ashitaka E, Oishi Y, Urade Y, Ito S: Involvement of S -nitrosylation of actin in inhibition of neurotransmitter release by nitric oxide. Mol Pain 2009, 5: 58. 10.1186/1744-8069-5-58PubMedCentralPubMedCrossRef
22.
Vaudry D, Stork PJ, Lazarovici P, Eiden LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296: 1648–1649. 10.1126/science.1071552PubMedCrossRef
23.
Sachs D, Cunha FQ, Ferreira SH: Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K + channel pathway. Proc Natl Acad Sci USA 2004, 101: 3680–3685. 10.1073/pnas.0308382101PubMedCentralPubMedCrossRef
24.
Narikawa K, Furue H, Kumamoto E, Yoshimura M: In vivo patch-clamp analysis of IPSCs evoked in rat substantia gelatinosa neurons by cutaneous mechanical stimulation. J Neurophysiol 2000, 84: 2171–2174.PubMed
25.
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 1991, 88: 7797–7801. 10.1073/pnas.88.17.7797PubMedCentralPubMedCrossRef
26.
Hope BT, Michael GJ, Knigge KM, Vincent SR: Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991, 88: 2811–2814. 10.1073/pnas.88.7.2811PubMedCentralPubMedCrossRef
27.
Mabuchi T, Matsumura S, Okuda-Ashitaka E, Kitano T, Kojima H, Nagano T, Minami T, Ito S: Attenuation of neuropathic pain by nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. Eur J Neurosci 2003, 17: 1384–1392. 10.1046/j.1460-9568.2003.02575.xPubMedCrossRef
28.
Abe T, Matsumura S, Katano T, Mabuchi T, Takagi K, Xu L, Yamamoto A, Hattori K, Yagi T, Watanabe M, Nakazawa T, Yamamoto T, Mishina M, Nakai Y, Ito S: Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 2005, 22: 1445–1454. 10.1111/j.1460-9568.2005.04340.xPubMedCrossRef
29.
Matsumura S, Kunori S, Mabuchi T, Katano T, Nakazawa T, Abe T, Watanabe M, Yamamoto T, Okuda-Ashitaka E, Ito S: Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472. Eur J Neurosci 2010, 32: 798–810. 10.1111/j.1460-9568.2010.07348.xPubMedCrossRef
30.
Xu L, Matsumura S, Mabuchi T, Takagi K, Abe T, Ito S: In situ measurement of neuronal nitric oxide synthase activity in the spinal cord by NADPH-diaphorase histochemistry. J Neurosci Methods 2006, 150: 174–184. 10.1016/j.jneumeth.2005.06.017PubMedCrossRef
31.
Xu L, Mabuchi T, Katano T, Matsumura S, Okuda-Ashitaka E, Sakimura K, Mishina M, Ito S: Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. Nitric Oxide 2007, 17: 18–24.PubMedCrossRef
32.
Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976, 73: 2424–2428. 10.1073/pnas.73.7.2424PubMedCentralPubMedCrossRef
33.
Fornai F, Lenzi P, Lazzeri G, Ferrucci M, Fulceri F, Giorgi FS, Falleni A, Ruggieri S, Paparelli A: Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity. Brain Res 2007, 1129: 174–190.PubMedCrossRef
34.
Aspenström P, Schutt CE, Lindberg U, Karlsson R: Mutations in β-actin: influence on polymer formation and on interactions with myosin and profilin. FEBS Lett 1993, 329: 163–170. 10.1016/0014-5793(93)80215-GPubMedCrossRef
35.
Dalle-Donne I, Milzani A, Giustarini D, di Simplicio P, Colombo R, Rossi R: S-NO-actin: S -nitrosylation kinetics and the effect on isolated vascular smooth muscle. J Muscle Res Cell Moti 2000, 21: 171–181. 10.1023/A:1005671319604CrossRef
36.
Schmidtko A, Gao W, Sausbier M, Rauhmeier I, Sausbier U, Niederberger E, Scholich K, Huber A, Neuhuber W, Allescher HD, Hofmann F, Tegeder I, Ruth P, Geisslinger G: Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent inflammatory pain. J Neurosci 2008, 28: 1320–1330. 10.1523/JNEUROSCI.5037-07.2008PubMedCrossRef
37.
Qian Y, Chao DS, Santillano DR, Cornwell TL, Nairn AC, Greengard P, Lincoln TM, Bredt DS: cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J Neurosci 1996, 16: 3130–3138.PubMed
38.
Schlossmann J, Hofmann F: cGMP-dependent protein kinases in drug discovery. Drug Discov Today 2005, 10: 627–634. 10.1016/S1359-6446(05)03406-9PubMedCrossRef
39.
Kunori S, Matsumura S, Okuda-Ashitaka E, Katano T, Audoly LP, Urade Y, Ito S: A novel role of prostaglandin E 2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia 2011, 59: 208–218. 10.1002/glia.21090PubMedCrossRef
40.
Furue H, Narikawa K, Kumamoto E, Yoshimura M: Responsiveness of rat substantia gelatinosa neurones to mechanical but not thermal stimuli revealed by in vivo patch-clamp recording. J Physiol 1999, 521: 529–535. 10.1111/j.1469-7793.1999.00529.xPubMedCentralPubMedCrossRef
41.
Furue H, Katafuchi T, Yoshimura M: In vivo patch-clamp technique. In Patch-Clamp Analysis: advanced techniques. 2nd edition. Edited by: Walz W. Totowa: Humana Press Inc; 2007:229–251.CrossRef
Metadata
Title
Rapid S-nitrosylation of actin by NO-generating donors and in inflammatory pain model mice
Authors
Jingshan Lu
Tayo Katano
Daisuke Uta
Hidemasa Furue
Seiji Ito
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2011
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-7-101

Other articles of this Issue 1/2011

Molecular Pain 1/2011 Go to the issue

Research

Autophagy impairment in a mouse model of neuropathic pain

Research

Specific involvement of atypical PKCζ/PKMζ in spinal persistent nociceptive processing following peripheral inflammation in rat

Research

A preconditioning nerve lesion inhibits mechanical pain hypersensitivity following subsequent neuropathic injury

Methodology

The Rat Grimace Scale: A partially automated method for quantifying pain in the laboratory rat via facial expressions

Research

Non-peptidergic small diameter primary afferents expressing VGluT2 project to lamina I of mouse spinal dorsal horn

Research

Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain